clinical trial · NCT07507903
OBPM_PANDA2026: Evaluation of the Performance and Safety of the Aktiia Periodic Optical Blood Pressure Monitoring Device
Aktiia SA·N/A·not yet recruiting·n = 200
HypertensionDevice under test evaluation against references
brief summary
This study, with N = 85 participants minimum over 3 visits spread over 7 days, has been designed to assess the accuracy and precision of the Blood Pressure and pulse rate values as generated by Aktiia.product-G1-US for up to 7 days after initialization in a cohort of subjects representative of the US population.
started
Apr 20, 2026
primary completion
Dec 31, 2026
completion
Dec 31, 2026
last updated
Apr 17, 2026
official title
OBPM_PANDA2026: Pivotal Evaluation of the Performance and Safety of the Aktiia Periodic Optical Blood Pressure Monitoring (OBPM) Device at Wrist Against Double Auscultation: a Multicenter Prospective Clinical Study
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol